Naturacare Expands with Acquisition of Sochim International
Deal News | Feb 27, 2025 | Cerea Partners SASU

Cerea Partners SASU, a private equity firm, in collaboration with BNP Paribas Asset Management, has arranged unitranche debt financing for Naturacare's strategic acquisition of Sochim International. This move consolidates Naturacare's position as a leading European Contract Development Manufacturing Organization (CDMO) in the dietary supplements sector. Naturacare, acquired by Dentressangle in October 2023, continues to expand its capabilities with the addition of Sochim’s expertise in softgel production, a complex form of dietary supplements. The acquisition follows previous collaborative financial arrangements by Cerea Partners, aimed at growing Naturacare’s market influence and production capabilities across Europe. Hubert Lange, Associate Director of Cerea Partners, and stakeholders like Unexo and Caisse d’Epargne Bretagne-Pays de la Loire, express strong backing for Naturacare's growth trajectory, which also includes strategic input from stakeholders such as Carlo Eigenmann of Sochim International.
Sectors
- Private Equity
- Pharmaceuticals and Biotechnology
- Finance
Geography
- France – Naturacare is based in France and Cerea Partners, a French private equity firm, played a significant role in arranging the financing.
- Italy – Sochim International, an Italian company specializing in softgel production, has been acquired, highlighting Italy's role in this transaction.
- Europe – The consolidation operation strengthens Naturacare's position among European CDMOs, indicating a strategic focus on the European market.
Industry
- Private Equity – The article revolves around the financing and strategic acquisitions facilitated by Cerea Partners, illustrating the role of private equity firms in M&A and expansion strategies.
- Pharmaceuticals and Biotechnology – Naturacare and Sochim International operate within the pharmaceuticals and biotechnology sector, focusing on the development and manufacture of dietary supplements.
- Finance – The article discusses financial transactions, including debt arrangement and stakeholder investments involving multiple financial institutions and asset management firms.
Financials
- 100 million – Annual revenue of Naturacare following the expansion.
Participants
Name | Role | Type | Description |
---|---|---|---|
Cerea Partners SASU | Financier | Company | Arranged the unitranche debt to finance Naturacare's acquisition of Sochim International. |
Naturacare | Target Company | Company | A CDMO specializing in dietary supplements, acquiring Sochim International to expand its capabilities. |
Sochim International | Selling Company | Company | An Italian company specializing in the production of softgels, acquired by Naturacare. |
DENTRESSANGLE | Acquiring Company | Company | Major shareholder of Naturacare, facilitating the company’s acquisition of Sochim International. |
BNP Paribas Asset Management | Co-Financier | Company | Collaborated with Cerea Partners to finance the acquisition through unitranche debt. |
Unexo | Investor | Company | Provided investment for the financing of the acquisition operation. |
Caisse d’Epargne Bretagne-Pays de la Loire | Co-Investor | Company | Participated alongside Unexo in the financing of Naturacare's acquisition. |
Carlo Eigenmann | Executive and Investor | Person | Founder of Sochim International, reinvested in Naturacare post-acquisition. |
Carolina Eigenmann | Executive | Person | Continues to serve as an executive at Sochim International post-acquisition. |
Hubert Lange | Associate Director at Cerea Partners | Person | Involved in orchestrating the financing for Naturacare’s acquisitions. |